Login to Your Account



NEWCO NEWS NEWS
Nearly two years after the Buck Institute for Research on Aging partnered with British firm Biotica Technology Ltd. to explore diseases of aging through the creation of Delos Pharmaceuticals Inc., a similar deal is afoot in the area of autoimmune disorders.

NEW DELHI – Indian biopharma company Vyome Biosciences raised almost $8 million in a second round of fundraising as part of a push to develop treatments for hard-to-treat skin conditions such as acne, persistent dandruff and bacterial and fungal skin infections.

SHANGHAI – For Xueming Qian, CEO and founder of Mabspace Co. Ltd., an antibody discovery engine based in Suzhou, the writing was on the wall. While pharma was de-emphasizing early stage research and putting it into the hands of biotechs in the U.S., the economy in China had hit an inflection point, the momentum was building.

More NEWCO NEWS Headlines

Cast Your Vote

Has biotech’s bubble burst?: